Allgens Medical Technology CO., LTD. (688613.SS)
CNY 18.52
(0.76%)
CNY 18.52
(0.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 69.28 Million CNY | -46.46% |
| 2022 | 118.37 Million CNY | -21.39% |
| 2021 | 148.63 Million CNY | 21.37% |
| 2020 | 111.91 Million CNY | 51.77% |
| 2019 | 87.46 Million CNY | 81.13% |
| 2018 | 42.28 Million CNY | 24.42% |
| 2017 | 32.08 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.96 Million CNY | -55.95% |
| 2024 Q3 | 2.03 Million CNY | -61.87% |
| 2024 Q1 | -2.11 Million CNY | 353.74% |
| 2023 Q4 | -4.68 Million CNY | -133.18% |
| 2023 Q2 | 19.94 Million CNY | 104.59% |
| 2023 Q1 | 9.74 Million CNY | -59.01% |
| 2023 FY | - CNY | -46.46% |
| 2023 Q3 | 14.12 Million CNY | -29.18% |
| 2022 Q1 | 2.95 Million CNY | -91.47% |
| 2022 Q2 | 30.32 Million CNY | 925.36% |
| 2022 FY | - CNY | -21.39% |
| 2022 Q4 | 23.77 Million CNY | -24.94% |
| 2022 Q3 | 31.68 Million CNY | 4.46% |
| 2021 FY | - CNY | 21.37% |
| 2021 Q2 | 36.58 Million CNY | 169.32% |
| 2021 Q1 | 13.58 Million CNY | 1122.33% |
| 2021 Q4 | 34.68 Million CNY | -8.26% |
| 2021 Q3 | 37.81 Million CNY | 3.36% |
| 2020 FY | - CNY | 51.77% |
| 2020 Q1 | -1.89 Million CNY | 94.65% |
| 2020 Q2 | 11.13 Million CNY | 686.9% |
| 2020 Q3 | 90.36 Million CNY | 711.81% |
| 2020 Q4 | 1.11 Million CNY | -98.77% |
| 2019 FY | - CNY | 81.13% |
| 2019 Q4 | -35.44 Million CNY | 0.0% |
| 2018 FY | - CNY | 24.42% |
| 2017 FY | - CNY | 0.0% |